ESR1 and breast cancer: The majority of BRCA1-deficient breast cancer cases are classified as triple-negative breast cancer based on the absence of expression of estrogen receptor (ER), progesterone receptor (PR), and HER29, and targeted therapy for this type of cancer is difficult.